Biosensors are analytical devices that combine a biological recognition element with a physical transducer to detect biological or chemical targets. In nanotechnology, biosensors often use nanoparticles, graphene, carbon nanotubes, quantum dots, nanowires, plasmonic structures, enzymes, antibodies, aptamers, DNA, or cell-based interfaces to improve sensitivity, selectivity, and response time. Their performance depends on recognition chemistry, immobilization, signal transduction, fouling resistance, stability, and sample complexity.
Biosensors matter because they enable rapid, portable, and potentially low-cost detection for healthcare, diagnostics, environmental monitoring, food safety, bioprocess control, and wearable health systems. They are studied for glucose monitoring, pathogen detection, cancer biomarkers, toxins, metabolites, nucleic acids, proteins, and continuous physiological monitoring. Nanoscale materials can amplify electrochemical, optical, mechanical, or plasmonic signals and support integration with wearable electronics, microfluidics, and sensors.
Conferences on biosensors appear in nanotechnology, biotechnology, analytical chemistry, biomedical engineering, diagnostics, and materials-science programs. Sessions often cover electrochemical biosensors, lab-on-a-chip systems, point-of-care testing, nanomaterial transducers, and biointerface engineering. Tracking biosensor events helps researchers follow how nanoscale platforms are being translated into practical biological measurement technologies.
To learn more, read our detailed glossary article on biosensors.